Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 1, 1999, Pages 316-325

  Bowman, Peggy ^a   Haikala, Heimo ^b   Paul, Richard J ^a,c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b ORION CORPORATION   (Finland)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CALCIUM; CALCIUM SENSITIZER; LEVOSIMENDAN; MILRINONE; MYOSIN LIGHT CHAIN; POTASSIUM CHLORIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; HEART MUSCLE; MUSCLE RELAXATION; NONHUMAN; PH MEASUREMENT; POTASSIUM TRANSPORT; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY; SWINE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; CALCIUM; CARDIOTONIC AGENTS; CORONARY VESSELS; HYDRAZONES; HYDROGEN-ION CONCENTRATION; MILRINONE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL CONTRACTION; PYRIDAZINES; SWINE; VASODILATOR AGENTS;

EID: 0032911582     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bradley AB and Morgan KG (1987) Alterations in cytoplasmic calcium sensitivity during porcine coronary artery contractions as detected by aequorin. J Physiol (Lond) 385:437-448.
2. de Lanerolle P and Paul RJ (1991) Myosin phosphorylation/dephosphorylation and regulation of airway smooth muscle contractility. Am J Physiol 261:L1-L14.
3. Dorn, GWD, Becker MW and Davis MG (1992) Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J Biol Chem 267:24897-24905.
4. Gruhn N, Nielsen-Kudsk JE Theilgaard S, Bang L, Olesen S-R and Aldershvile J (1998) Coronary vasorelaxant effect of levosimendan, a new inodilator with calcium sensitizing properties. J Cardiovasc Pharmacol 31:741-749.
5. ++ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
6. Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J and Linden IB (1995a) Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 27:1859-1866.
7. Haikala H Levijoki J and Linden IB (1995b) Troponin C-mediated calcium sensitization by levosimendan accelerates the proportional development of isometric tension. J Mol Cell Cardiol 27:2155-2165.
8. Haikala H and Linden IB (1995) Mechanisms of action of calcium-sensitizing drugs. J Cardiovasc Pharmacol 26 (Suppl 1): S10-S19.
9. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won KJ, and Sato K (1997) Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 49:157-230.
10. ++-dependent protein switches in actomyosin based contractile systems, Int J Biochem Cell Biol 27:97-108.
11. ++ in vascular smooth muscle. Eur J Pharmacol 178:171-177.
12. i in porcine coronary artery smooth muscle. Circ Res 75:990-998.
13. Ngai JH, Roth PS and Paul RJ (1990) Effects of endothelium on basal tone and agonist and O2 sensitivity in porcine coronary artery. J Pharmacol Exp Ther 252:1053-1059.
14. Pagel PS, Hettrick DA and Warltier DC (1996) Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs. Br J Pharmacol 119:609-615.
15. Persechini A, Moncrief ND and Kretsinger RH (1989) The EF-hand family of calcium-modulated proteins. Trends Neurosci 12:462-467.
16. ++ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modeling, fluorescence probe, and proton nuclear magnetic resonance study [published erratum appears in J Biol Chem 270:2880]. J Biol Chem 269:28584-28590.
17. Rubanyi G and Paul RJ (1985) Two distinct effects of oxygen on vascular tone in isolated porcine coronary arteries. Circ Res 56:1-10.
18. Rump AF, Acar D, Rosen R and Klaus W (1994) Functional and antiischaemic effects of the phosphodiesterase inhibitor levosimendan in isolated rabbit hearts. Pharmacol Toxicol 74:244-248.
19. Schafer BW and Heinzmann CW (1996) The S100 family of EF-hand calcium-binding proteins: Function and pathology. Trends Biochem Sci 21:134-140.
20. Silver PJ, Lepore RE, O'Connor B, Lemp BM, Hamel LT, Bentley RG, and Harris, AL (1988) Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone. J Pharmacol Exp Ther 247:34-42.
21. Sumiyoshi R, Nishimura J, Kawasaki J, Kobayashi S, Takahashi S and Kanaide H (1997) Diadenosine polyphosphates directly relax porcine coronary arterial smooth muscle. J Pharmacol Exp Ther 283:548-556.
22. Thomas JA, Buchsbaum RN, Zimniak A and Racker, E (1979) Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 18:2210-2218.
23. ++ entry to contraction in rat aorta. J Pharmacol Exp Ther 285:759-766.
24. Udvary E, Papp JG and Vegh A (1995) Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction. Br J Pharmacol 114:656-661.
25. Vegh A, Papp JG, Udvary E and Kaszala K (1995) Hemodynamic effects of calcium-sensitizing agents. J Cardiovasc Pharmacol 26 (Suppl 1): S20-31.
26. Walsh MP (1990) Smooth muscle caldesmon. Prog Clin Biol Res 327:127-140.
27. Wray S (1988) Smooth muscle intracellular pH: Measurement, regulation, and function. Am J Physiol 254:C213-C225.
28. + channel in rat arterial myocytes. Eur J Pharmacol 333:249-259.